Tech Company Inital Public Offerings
Acutus Medical IPO
Acutus Medical was acquired by . Shares were listed on 8/6/2020.
Transaction Overview
Company Name
Announced On
8/6/2020
Transaction Type
IPO
Amount
$158,400,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering as follows: approximately $40.0 million to support our commercial expansion, including hiring additional commercial personnel, approximately $22.0 million for the completion of all of our ongoing clinical trials, which includes our RECOVER AF PMA, PLASZMA trial, ablation catheter IDEs and DISCOVER registry, approximately $24.0 million for research and development activities, and the remainder for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
2210 Faraday Ave. 100
Carlsbad, CA 92008
USA
Carlsbad, CA 92008
USA
Phone
Website
Email Address
Not Recorded
Overview
At Acutus Medical (Nasdaq: AFIB), our goal is simple: create superior outcomes for patients with Atrial Fibrillation (AF). We deeply understand the effects that AF has on people's lives, which is why we've pioneered a transformational treatment featuring the only real-time arrhythmia visualization system.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/6/2020: ANA Therapeutics venture capital transaction
Next: 8/6/2020: Kyber Data Science venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs